Target
Kallikrein-1
Ligand
BDBM50157089
Substrate
n/a
Meas. Tech.
ChEMBL_302558 (CHEMBL839521)
Ki
379±n/a nM
Citation
 Bruncko, MMcClellan, WJWendt, MDSauer, DRGeyer, ADalton, CRKaminski, MAWeitzberg, MGong, JDellaria, JFMantei, RZhao, XNienaber, VLStewart, KKlinghofer, VBouska, JRockway, TWGiranda, VL Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties. Bioorg Med Chem Lett 15:93-8 (2004) [PubMed]  Article 
Target
Name:
Kallikrein-1
Synonyms:
KLK1 | KLK1_HUMAN | Kallikrein 1 | Kallikrein-1 | Kidney/pancreas/salivary gland kallikrein | Tissue kallikrein
Type:
Enzyme
Mol. Mass.:
28874.69
Organism:
Homo sapiens (Human)
Description:
P06870
Residue:
262
Sequence:
MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS
  
Inhibitor
Name:
BDBM50157089
Synonyms:
8-Bromo-6-(2-phenyl-cyclopropyl)-naphthalene-2-carboxamidine | CHEMBL181599
Type:
Small organic molecule
Emp. Form.:
C20H17BrN2
Mol. Mass.:
365.266
SMILES:
NC(=N)c1ccc2cc(cc(Br)c2c1)C1CC1c1ccccc1
Structure:
Search PDB for entries with ligand similarity: